Cefuroxime and Peginterferon drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Cefuroxime and Peginterferon together. This study is created by eHealthMe based on reports of 7 people who take Cefuroxime and Peginterferon from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on cefuroxime sodium and peginterferon alfa-2a; ribavirin (the active ingredients of Cefuroxime and Peginterferon, respectively), and Cefuroxime and Peginterferon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Cefuroxime?

Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. (latest outcomes from Cefuroxime 7,993 users)

What is Peginterferon?

Peginterferon has active ingredients of peginterferon alfa-2a; ribavirin. It is often used in hepatitis c. (latest outcomes from Peginterferon 13,028 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

7 people who take Cefuroxime, Peginterferon are studied.


Number of reports submitted per year:

Cefuroxime and Peginterferon drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Syncope (loss of consciousness with an inability to maintain postural tone)
  2. Visual impairment
  3. Weight decreased
  4. Wound infection
  5. Dehydration (dryness resulting from the removal of water)
  6. Migraine (headache)
  7. Abdominal discomfort
  8. Alanine aminotransferase increased
  9. Alcohol abuse
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)
1 - 6 months:
  1. Dehydration (dryness resulting from the removal of water)
  2. Migraine (headache)
  3. Abdominal discomfort
  4. Alanine aminotransferase increased
  5. Alcohol abuse
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Arthralgia (joint pain)
  8. Bradycardia (abnormally slow heart action)
  9. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  10. Chest pain
6 - 12 months:
  1. Abdominal discomfort
  2. Alanine aminotransferase increased
  3. Dizziness
  4. Drug dependence
  5. Dry skin
  6. Dyspepsia (indigestion)
  7. Ear discomfort
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  9. Gastritis (inflammation of stomach)
  10. Gastroenteritis (inflammation of stomach and intestine)
1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Abdominal discomfort
  2. Alanine aminotransferase increased
  3. Alcohol abuse
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Arthralgia (joint pain)
  6. Bradycardia (abnormally slow heart action)
  7. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  8. Chest pain
  9. Circulatory collapse
  10. Decreased appetite

Most common drug interactions by gender *:

female:
  1. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  2. Chest pain
  3. Circulatory collapse
  4. Decreased appetite
  5. Dizziness
  6. Drug dependence
  7. Dry skin
  8. Dyspepsia (indigestion)
  9. Ear discomfort
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
male:
  1. Dehydration (dryness resulting from the removal of water)
  2. Migraine (headache)
  3. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:
  1. Arthralgia (joint pain)
  2. Bradycardia (abnormally slow heart action)
  3. Bulimia nervosa (eating disorder characterized by recurrent binge eating, followed by compensatory behaviours)
  4. Chest pain
  5. Circulatory collapse
  6. Decreased appetite
  7. Dizziness
  8. Drug dependence
  9. Dry skin
  10. Dyspepsia (indigestion)
40-49:

n/a

50-59:
  1. Dehydration (dryness resulting from the removal of water)
  2. Migraine (headache)
  3. Leukopenia (less number of white blood cells in blood)
  4. Thrombocytopenia (decrease of platelets in blood)
60+:
  1. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

* Approximation only. Some reports may have incomplete information.


Do you take Cefuroxime and Peginterferon?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Cefuroxime and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Peginterferon and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Cefuroxime and Peginterferon
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Cefuroxime and Peginterferon



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.